Medical Futures Inc. Announces New Board Member
Accomplished Pharmaceutical Executive, John Suk, Appointed to Medical Futures Inc. Board of Directors
(firmenpresse) - RICHMOND HILL, ONTARIO -- (Marketwire) -- 12/13/11 -- Medical Futures Inc. (MFI) is pleased to introduce John Suk, a newly appointed board member. John Suk is a well-rounded executive who has spent over 25 years working in large multi-national pharmaceutical companies such as Nycomed, Roche and GlaxoSmithKline.
"John Suk brings with him a wealth of knowledge to support the continued growth of MFI. He represents a strong, and strategic addition to our board of directors and will serve as a valuable asset to our team moving forward, particularly with our upcoming launch of Durela™, a new option in pain treatment".-Colin Campbell, CEO.
John is the former (retired 2011) CEO of Nycomed Canada Inc. having started the company as Byk Canada in 1997. As an illustration of his success in the industry Nycomed has been listed as one of the Top Ten Best Workplaces in Canada for several years and has enjoyed great success in the Canadian Pharmaceutical market specifically in Gastrointestinal, Respiratory and Pain markets. Recently Nycomed was sold internationally to Takeda of Japan.
Currently, John also serves on the Brock University Board and is Chair of Finance & HR committee at Brock. He is also on the board of Exciton Technologies in Edmonton, serving as Vice Chair and is a Director of Ultimate Kiosks in Niagara. John and his wife Susan live in St. Catharines, and have 3 adult children and 2 grandchildren.
"I am delighted to be joining Medical Futures at this important juncture in its history with strong growth and important product launches. I feel my experience in pharmaceuticals will be an asset to the company, and that Medical Futures will continue to develop as an innovative player in the Canadian Pharmaceutical marketplace."- John Suk, current President Xigera Inc.
About Medical Futures Inc.
Medical Futures Inc. is an innovative pharmaceutical company that has a focus on Gastroenterology, Pain Management, and Women's Health. We provide Canadians with safe, effective and affordable products to help improve the overall quality of their lives. Our current product offering includes: Durela™ Florastor® Iberogast® Proferrin® Pegalax™ Mutaflor® Purfem™ Moviprep®.
Contacts:
Medical Futures Inc.
Colin Campbell
CEO
905-731-0294
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.12.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 96264
Anzahl Zeichen: 5454
contact information:
Town:
RICHMOND HILL, ONTARIO
Kategorie:
Equipment & Supplies
Diese Pressemitteilung wurde bisher 214 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medical Futures Inc. Announces New Board Member"
steht unter der journalistisch-redaktionellen Verantwortung von
Medical Futures Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
